Dividend
Market Wrap: The Papa's Have It; France is Still AAA-OK!; A Pinch of Apple; Making Coffee into Juice
View Older Stories
-
Merck Executing on Strategy to Position Company for Long-Term Sustainable Growth
-
Merck (MRK) Has Attractive Dividend, Growth Potential - Barron's
-
UPDATE - Barclays Downgraded Pfizer (PFE) to Equalweight; Inferior Revenue Recovery Post 'Patent Cliff' Through 2020
-
Notable Stocks Trading Ex-Dividend Tomorrow 09/13: (MRK) (DLR) (LEG) (KO) (BR)
-
Q2 Preview: Divide and Conquer May Not Be Pfizer's (PFE) Best Option; Pipeline Looks Strong
-
Merck & Co., Inc. (MRK) Declares $0.38 Quarterly Dividend; 4.3% Yield
-
Barclays on U.S. Major Pharmaceuticals: Pipelines Revived? Making Strides in Oncology, Cardiology, and Virology
-
Merck (MRK) Declares $0.38 Quarterly Dividend; 4.1% Yield
-
Merck (MRK) Declares $0.38 Quarterly Dividend; 4.7% Yield
-
Wells Fargo on Large Cap Pharma: Upgrading To Overweight
-
Wells Fargo Starts Merck (MRK) at Outperform; Well Positioned Among Peers As Patent Cliff Looms
-
Merck & Co. (MRK) Declares $0.38 Quarterly Dividend; 4.4% Yield
-
Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
-
Merck & Co. (MRK) Declares $0.38 Quarterly Dividend; 4.3% Yield
-
T2's Tilson Makes the Case For Blue Chips: Anheuser-Busch (BUD), Microsoft (MSFT) and BP (BP)
-
Merck & Co. (MRK) Declares $0.38 Quarterly Dividend; 4.7% Yield
-
Merck (MRK) Declares $0.38 Quarterly Dividend; 4.1% Yield
-
While Attention Is on a Pfizer (PFE) Dividend Raise, Merck (MRK) Could Be Ripe for a Hike Too - Analyst
-
Goldman Sachs Removed Abbott Labs (ABT) From Buy List, Eli Lilly (LLY) From Sell List
-
Merck (MRK) Declares $0.38 Quarterly Dividend; 4.1% Yield; Announces $3B Common Buyback
-
Notable Mergers and Acquisitions of the Day: MRK/SGP, SNS, CDCS
-
Merck (MRK) Declares Qtr. Dividend of $0.38, Yielding 5.10%
-
After-Hours Movers 6/10: MBRX, PALM, PLXS Higher; ATPG, ATU, VMC, LUB Lower
-
Merck (MRK) Declares Qtr. Dividend of $0.38/Share, Yielding 5.80%
-
Morning Movers 4/21: ELX, THC, COH, PKG, HWG, USG Higher; ZION, LAB, NTRS, HBAN, BK, NYT Lower
-
Unusual 11 Mid-Day Movers 4/9: TXT, APWR, BAC, CRME Higher; FAZ, HPT, MTRX, ANF Lower
-
Morning Movers 4/9: TXT, WFC, APWR, CRME, USB, EXM, BAC, GYMB, CSH Higher; MOV, ELMG, ANF Lower
-
Bernstein Upgrades Merck & Co. Inc. (MRK) to Outperform
-
Jefferies Downgrades Genentech (DNA) to Hold
-
Morning Movers 3/9: Schering-Plough (SGP) Higher On Merck (MRK) Merger, Stem Cell Stocks Rock On Obama Move To Lift Funding Restrictions
-
Did the Merck/Schering-Plough (SGP) Deal Leak On Friday To a Chosen Few?
-
Already Speculation Johnson & Johnson (JNJ) Could Make Counter-Bid for Schering-Plough (SGP) - CNBC
-
Merck (MRK) To Acquire Schering-Plough (SGP) In $41 Billion Deal
-
Merck (MRK) Declares $0.38/Sh Qtr Dividend, Yielding 5.4%
-
Top 10 News Items 2/2-2/6: Geithner to Release Bailout Plan Monday; Unemployment Rate Jumps to 7.6%; BofA Reverses on Insider Buys
-
Merck (MRK) Highlights From Q4 Conference Call- Trims Gardasil Forecast, Committed To Current Dividend
-
Morning Movers 2/3: DryShips (DRYS) Up Loan Restructuring; Motorola (MOT) Lower on Results/Dividend Cut
-
Merck (MRK) Tops Q4 Views; Reaffirms Outlook
-
Unusual 11 Mid-Day Movers 12/19: PBKS, EAT, SLH, DRI Higher; ARTC, UFI, DVAX, EGLE Lower
-
Merck (MRK) Reaffirms FY08, But Guides FY09 EPS Below The Street
-
Merck & Co. (MRK) Declares $0.38/Sh Qtr Dividend
-
Citi Issues List of 50 Highest Dividend Yield Stocks (MIC, FLY, AYR, GCI, OMX, STI, More...)
-
Pre-Open Movers 9/18: Investment Banks Still Under Pressure (GS, MS); WaMu (WM) Up On Deal Reports
-
After-Hours Movers 9/17: Constellation Energy (CEG) Up on Possible Bid; ProLogis (PLD) Lower on Guidance
-
David Moenning's Daily State of the Markets: 9/10
